Found 2860 matching trials
Human Upper Extremity Allotransplantation PHASE2 Background: Millions of people each year sustain injuries, have tumors surg...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor PHASE2 The purpose of this study is to determine whether ATIR is safe and effectiv...
Show More Location
Algemeen Ziekenhuis Sint-Jan
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients PHASE1 The study is an open-label Phase 1 single dose-escalation safety study of C...
Show More Location
Mayo Clinic Florida
Learn More & Join Trial
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas PHASE1 This is a clinical trial to evaluate the feasibility and safety of giving t...
Show More Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Learn More & Join Trial
Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD PHASE2 Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Show More Location
Hospital Maissoneuve
Learn More & Join Trial
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL) PHASE2 The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma PHASE1 This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Show More Location
Shandong Second Provincial General Hospital
Learn More & Join Trial
CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells PHASE1 The purpose of this study is to collect data on the safety and potential ef...
Show More Location
Roger Williams Medical Center
Learn More & Join Trial